Valued at USD 677.23 million in 2024, the global beta-glucan market is estimated at USD 731.27 million in 2025 and is projected to reach USD 1,483.88 million by 2034, growing at a CAGR of 8.20% during the forecast period 2025–2034, according to Polaris Market Research. Increasing health consciousness is identified as the key driving factor. This article reviews how consumer awareness, new applications, and evolving rules are shaping the competitive landscape for B2B suppliers.
Wellness Awareness and Disease Burden Drive Demand
The beta-glucan market has surged in recent years, largely propelled by increasing health consciousness. As consumers actively seek products offering functional benefits such as immune support, cardiovascular health, and weight management, beta-glucans have gained attention as a natural ingredient with immune-modulating properties and potential to reduce cholesterol levels.
Demand is also supported by the burden of chronic diseases. The report cites the World Health Organization, which states that illnesses such as heart problems, strokes, cancer, and diabetes cause over 70% of deaths worldwide. Together with an aging population and a stronger focus on preventing illness, this has led consumers to turn to dietary supplements, functional foods, and beverages fortified with beta-glucans.
Skincare Expands the Application Base
Beta-glucan in skincare is gaining significant attention in the beauty industry. The report states that beta-glucans are good for the skin and help reduce inflammation, and that they are used in many skin care products to make skin look younger and keep it healthy. They also help protect cells from damage and reduce irritation and redness. Because of these healing and calming benefits, the report notes, many consumers are choosing beta-glucan over hyaluronic acid.
Browse Insights:
https://www.polarismarketresearch.com/industry-analysis/beta-glucan-market
New methods of extracting beta-glucan from plants and processing it into products are helping the market grow further, and the increasing popularity of herbal remedies is cited as a rising trend. Innovation in formulations and delivery systems is broadening use across pharmaceuticals, food and beverage, cosmetics, and animal nutrition. In February 2025, Layn Natural Ingredients announced a new beta-glucan ingredient and opened a biotechnology facility. For ingredient suppliers, functional foods and cosmetic applications represent adjacent routes to market.
Labeling and Claims Rules Remain the Primary Restraint
The report identifies regulatory challenges as a restraining factor. Companies have met difficulties from regulations on labelling and distribution, and the European Food Safety Authority (EFSA) has set strict rules on the use of beta-glucan in cosmetics.
Regulations on health claims and labeling vary across regions, and the lack of standardized definitions for health claims is a primary hurdle. Because countries and regions apply different frameworks to health claims on food and dietary supplement labels, market access becomes more complex and manufacturers find it harder to communicate product benefits effectively. These regulatory challenges make clinical evidence and regional compliance planning essential.
Regional and Competitive Dynamics
North America registered the largest share of the global market in 2024, with the report attributing its dominance to wide use across different products and their related health advantages. Asia Pacific is expected to see significant growth, driven by greater awareness of health benefits and an expanding dietary supplement sector. The report segments the market by source, functionality, purity, and region, with the regional scope covering North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Leading companies are investing heavily in R&D to improve products and find new uses in food and beverages, pharmaceuticals, and cosmetics. Many are funding human trials to prove health benefits, which helps them differentiate and obtain approval for health claims. Major players include Alltech, Angel Yeast Co. Ltd, Associated British Foods Plc, Bigrigin, Ceapro, Inc., dsm-Firmenich, Garuda International Inc., Kemin Industries, Kerry Group plc, Lallemand, Leiber, Lesaffre, Merck, NutriScience Innovations, LLC, and Tate & Lyle PLC.
Strategic Takeaway for B2B Stakeholders
With the beta-glucan projected to reach USD 1,483.88 million by 2034, suppliers that combine evidence-backed health positioning, expansion into beta-glucan in skincare, and proactive management of regulatory challenges are well placed to capture the opportunity.
More Trending Latest Reports By Polaris Market Research:
earth-observation-small-satellite-market
building-information-modeling-market